Sohini Das

All stories by Sohini Das

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Rediff.com6 days ago

So far, no other vaccine has been approved globally for children below 12 years. Sohini Das reports.

Trade margins capped at 70% for oximeters, BP meters, other medical devices

Trade margins capped at 70% for oximeters, BP meters, other medical devices

Rediff.com14 Jul 2021

The medical devices, which have been in high demand during the Covid-19 pandemic, will now see a drop in prices, as the earlier margins were up to 709 per cent for some of these products.

Serum to double Covid vaccine output in 2022

Serum to double Covid vaccine output in 2022

Rediff.com13 Jul 2021

SII would be scaling up its AstraZeneca-Oxford vaccine manufacturing capacity to 200 million doses a month from 100 million a month now, reports Sohini Das.

Explained: What the Brazil-Covaxin row is about

Explained: What the Brazil-Covaxin row is about

Rediff.com9 Jul 2021

Three entities are at the centre of this controversy: The Brazilian government, Bharat Biotech and a Singapore-based company called Madison Biotech.

India may get 4m doses of Pfizer, Moderna by August from COVAX

India may get 4m doses of Pfizer, Moderna by August from COVAX

Rediff.com8 Jul 2021

However, before the Moderna and Pfizer messenger ribonucleic acid (or mRNA) vaccines come to India via this route, the legalities around the indemnity clause will have to be settled, reports Sohini Das.

Why Thyrocare sold out to PharmEasy

Why Thyrocare sold out to PharmEasy

Rediff.com5 Jul 2021

'I have done enough work for many years.' 'This is a decision that many people at my age need to review.' 'I may become an exit example for people to study.'

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Rediff.com2 Jul 2021

By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.

'Covid vaccines are working against new variants'

'Covid vaccines are working against new variants'

Rediff.com2 Jul 2021

'The key purpose of vaccination is to prevent hospitalisation, severe disease, and death.' 'All vaccines work equally, although mild disease cannot be prevented.'

Serum applies for EU Covishield nod through AstraZeneca

Serum applies for EU Covishield nod through AstraZeneca

Rediff.com30 Jun 2021

We have applied for marketing authorisation to the EMA through AstraZeneca. We will not sell the vaccine in the EU, said a company source.

India's children may get 2 Covid vaccines by December

India's children may get 2 Covid vaccines by December

Rediff.com28 Jun 2021

While Bharat Biotech's Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been approved for adolescents in the United States; and Cadila Healthcare's ZyCoV-D has done trials on 12 year-olds and above already, reports Sohini Das.

Covid: What is Delta, Delta Plus & can vaccines fight it?

Covid: What is Delta, Delta Plus & can vaccines fight it?

Rediff.com24 Jun 2021

While virologists say theoretically the vaccine that works on Delta should work on the Delta Plus variant as well, more research is needed.

Novavax set for India launch with Serum Institute as partner

Novavax set for India launch with Serum Institute as partner

Rediff.com15 Jun 2021

The Covid-19 vaccine demonstrated an overall 90.4 per cent efficacy in phase 3 clinical trials, reports Sohini Das

India could get 4th Covid vaccine as Zydus Cadila set to seek nod for ZyCoV-D

India could get 4th Covid vaccine as Zydus Cadila set to seek nod for ZyCoV-D

Rediff.com14 Jun 2021

This could also be India's first vaccine for children aged 12 years and above as the company has conducted trials on the age group. The decision, however, lies with the regulator, reports Sohini Das

Study comparing Covishield, Covaxin has limitations: Bharat Biotech

Study comparing Covishield, Covaxin has limitations: Bharat Biotech

Rediff.com9 Jun 2021

Raches Ella, project lead, Covid-19 vaccines at Bharat Biotech said in a series of tweets that he was 'surprised' that media and researchers were drawing conclusions based on non-peer reviewed work.

COVID-19 Vaccine: 4 months from lab to jab

COVID-19 Vaccine: 4 months from lab to jab

Rediff.com8 Jun 2021

'Almost 70 per cent production time of a vaccine is dedicated to quality control, which is done through several hundred tests.'

Biological E inks deal with Canadian firm for mRNA Covid vaccine

Biological E inks deal with Canadian firm for mRNA Covid vaccine

Rediff.com2 Jun 2021

Providence will sell up to 30 mn doses of its mRNA vaccine to Biological E. It would also provide the necessary technology transfer to make the vaccine in India, with a minimum production capacity of 600 mn doses in 2022 and targets capacity of 1 bn doses, reports Sohini Das.

Bharat Biotech to make 900 million Covaxin vaccines

Bharat Biotech to make 900 million Covaxin vaccines

Rediff.com1 Jun 2021

500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.

DRDO's Covid drug: Benefits. Concerns

DRDO's Covid drug: Benefits. Concerns

Rediff.com31 May 2021

Commercial launch and supply to major government and private hospitals is expected in mid-June.

Self-use Covid-19 testing kits to be available at stores for Rs 250

Self-use Covid-19 testing kits to be available at stores for Rs 250

Rediff.com21 May 2021

Pune's Mylab Discovery Solutions' CoviSelf, which gives results in 15 minutes, gets ICMR nod

Cipla ready to partner in Covid vaccine distribution

Cipla ready to partner in Covid vaccine distribution

Rediff.com17 May 2021

However, Cipla was very clear it does not want to get into vaccine manufacturing.

Next